C
C Scarborough
Researcher at University of Oxford
Publications - 2
Citations - 518
C Scarborough is an academic researcher from University of Oxford. The author has contributed to research in topics: Randomized controlled trial & Context (language use). The author has an hindex of 2, co-authored 2 publications receiving 306 citations.
Papers
More filters
Journal ArticleDOI
Oral versus intravenous antibiotics for bone and joint infection
Li H-K.,Li H-K.,Ines Rombach,Rhea Zambellas,A S Walker,Martin A. McNally,B Atkins,Benjamin A. Lipsky,Harriet Hughes,D Bose,Michelle Kümin,C Scarborough,Philippa C Matthews,Andrew Brent,J Lomas,Roger Gundle,M Rogers,Adrian Taylor,Brian Angus,I. Byren,Anthony R. Berendt,S Warren,S Warren,F E Fitzgerald,Mack Djf.,Mack Djf.,Susan Hopkins,J Folb,Helen Reynolds,Elinoor Moore,John Marshall,N. Jenkins,C E Moran,A F Woodhouse,S Stafford,R.A. Seaton,C Vallance,C J Hemsley,K Bisnauthsing,Sandoe Jat.,I Aggarwal,S C Ellis,D J Bunn,R K Sutherland,Gavin Barlow,Cyrus Cooper,Claudia Geue,Nicola McMeekin,Andrew Briggs,Parham Sendi,E Khatamzas,Tri Wangrangsimakul,Wong Thn.,Lucinda Barrett,Abtin Alvand,C F Old,Jennifer Bostock,John Paul,Graham S Cooke,Guy E. Thwaites,Philip Bejon,Philip Bejon,M Scarborough,M Scarborough +63 more
TL;DR: Oral antibiotic therapy was noninferior to intravenous antibiotic therapy when used during the first 6 weeks for complex orthopedic infection, as assessed by treatment failure at 1 year after randomization.
Journal ArticleDOI
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
Matthew Scarborough,H K Li,H K Li,Ines Rombach,Rhea Zambellas,A S Walker,Martin McNally,Bridget L. Atkins,Michelle Kümin,Benjamin A. Lipsky,H Hughes,D Bose,S Warren,Damien Mack,Damien Mack,J Folb,E Moore,Neil Jenkins,Susan Hopkins,R.A. Seaton,C Hemsley,Jonathan Sandoe,I Aggarwal,S C Ellis,R K Sutherland,Claudia Geue,Nicola McMeekin,C Scarborough,John Paul,Graham S Cooke,Jennifer Bostock,E Khatamzas,N Wong,A J Brent,J Lomas,Philippa C Matthews,Philippa C Matthews,Tri Wangrangsimakul,Roger Gundle,M Rogers,Adrian Taylor,Guy E. Thwaites,Philip Bejon +42 more
TL;DR: PO antibiotic therapy is non-inferior to IV therapy when used during the first 6 weeks in the treatment for bone and joint infection, as assessed by definitive treatment failure within 1 year of randomisation.